Toward a unified nomenclature for mammalian ADP-ribosyltransferases.

By M. Hottiger, P. Hassa, B. Lüscher, H. Schüler, F. Koch-Nolte. TIBS -Trends in Biochemical Sciences. Regular ed, 2010

814 citations recorded by the source corpus.

Subfields: Immunology, Oncology, Physiology

View Paper: https://www.semanticscholar.org/paper/00ea4a6688c64d34e339368dd9c537643bef9f1c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. W. Kraus

In Oncology

1. Rebecca Gupte
2. Ziying Liu
3. W. Kraus
4. Bryan A. Gibson

In Physiology

1. W. Kraus
2. Bryan A. Gibson

Citations in the corpus

• The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets (2010, neutral): “…(ARTs) has been proposed to recognize that fact that (1) PARPs catalyze a transferase reaction, not a template-dependent polymerization reaction; and (2) not all family members have PARP activity; some are likely to function as mono(ADP-ribosyl) transferases (mARTs) (Hottiger et al., 2010).”
• PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes (2017, methodology): “Hottiger et al. (2010) have proposed using the term ARTD, which represents the basic catalytic activity of the proteins.”
• New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs (2012, methodology): “*Based on the revised nomenclature of Hottiger et al.(15).”